Out-licensing

Methods and assays which may be used to diagnose and follow the progression of cancers associated with c-Met expression More

This technology involves the generation of several novel mouse monoclonal antibodies against a sub-domain of an MITF fragment that is cleaved during cell death. More

The compositions and methods of administration described in this invention are based on indole carbazole, which causes terminal differentiation of tumor cells by exploiting a normal physiologic pathway. More

Rabbit polyclonal antibodies that recognize the human and mouse S100A15 proteins More

In vitro and ex vivo methods of screening for modulators, homologues, and mimetics of LF mitogen activated protein kinase kinase (MAPKK) protease activity. More

Lysosomal acid ceramidase alteration is related to Farber disease and probably to cancer. We offer a fast and sensitive (pmol) fluorimetry method – current methods use radioactivity – to measure its level, with no interferences from other ceramidases More

This newly discovered function of MUC1 presents a novel target for the development of new cancer therapies and diagnostics. More